• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于皮肤黑色素瘤早期诊断教育活动的经济评估

Economic evaluation of an educational campaign for early diagnosis of cutaneous melanoma.

作者信息

Garattini L, Cainelli T, Tribbia G, Scopelliti D

机构信息

Centre for Health Economics, Mario Negri Institute for Pharmacological Research, Ranica, Italy.

出版信息

Pharmacoeconomics. 1996 Feb;9(2):146-55. doi: 10.2165/00019053-199609020-00006.

DOI:10.2165/00019053-199609020-00006
PMID:10160093
Abstract

Public educational campaigns for the early diagnosis of cutaneous melanoma are considered an effective approach in the prevention of this disease, since they increase the number of cases detected early and consequently lengthen patients' life expectancy. We performed an economic evaluation of such a campaign in Bergamo, Italy, in order to quantify its costs and consequences. We used cost-effectiveness analysis to compare the costs and effects of the campaign with those of the 'do nothing' option. The analysis was performed from the perspective of the Italian National Health Service [the Servizio Sanitario Nazionale (SSN)]. Accordingly, only direct costs related to publicly financed healthcare services were considered. No indirect costs or benefits were considered because they are not relevant to the SSN. Incremental analysis was used to obtain results in terms of additional costs per life-year saved (LYS). Overall LYS were quantified by comparing the survival curves for 4 subgroups of patients with different lesional thicknesses at diagnosis ( < 0.76mm, 0.76 to 1.50mm, 1.51 to 3.00mm and > 3.00mm). All costs were estimated in 1993 Italian lire (L). Overall effectiveness amounted to 233.49 LYS. Using a 5% discount rate, the value of effectiveness was 171.3 LYS. The total cost of the educational campaign (i.e. the sum of the organisational and 'induced' costs minus the costs saved) was estimated at L817 million (approximate 1993 exchange rate $US1 = L1573), and L905 million after discounting at a rate of 5%. Thus, using discounted cost and effectiveness data, the cost of the educational campaign was L5.28 million per LYS.

摘要

开展公众教育活动以实现皮肤黑色素瘤的早期诊断,被认为是预防该疾病的一种有效方法,因为这会增加早期发现的病例数量,从而延长患者的预期寿命。我们在意大利贝加莫对这样一项活动进行了经济评估,以量化其成本和效果。我们采用成本效益分析方法,将该活动的成本和效果与“不作为”方案进行比较。该分析是从意大利国家医疗服务体系[国家卫生服务局(SSN)]的角度进行的。因此,只考虑与公共资助医疗服务相关的直接成本。未考虑间接成本或效益,因为它们与SSN无关。采用增量分析来得出每挽救一个生命年(LYS)的额外成本方面的结果。通过比较诊断时不同病灶厚度(<0.76mm、0.76至1.50mm、1.51至3.00mm和>3.00mm)的4个患者亚组的生存曲线,对总体LYS进行了量化。所有成本均以1993年意大利里拉(L)估算。总体效果为233.49个LYS。采用5%的贴现率时,效果值为171.3个LYS。教育活动的总成本(即组织成本与“诱导”成本之和减去节省的成本)估计为8.17亿里拉(1993年近似汇率1美元 = 1573里拉),按5%的贴现率贴现后为9.05亿里拉。因此,根据贴现后的成本和效果数据,教育活动的成本为每LYS 528万里拉。

相似文献

1
Economic evaluation of an educational campaign for early diagnosis of cutaneous melanoma.一项关于皮肤黑色素瘤早期诊断教育活动的经济评估
Pharmacoeconomics. 1996 Feb;9(2):146-55. doi: 10.2165/00019053-199609020-00006.
2
Analysis of the cost-effectiveness ratio of the health campaign for the early diagnosis of cutaneous melanoma in Trentino, Italy.意大利特伦蒂诺地区皮肤黑色素瘤早期诊断健康运动的成本效益比率分析。
Cancer. 1993 Jan 15;71(2):370-4. doi: 10.1002/1097-0142(19930115)71:2<370::aid-cncr2820710217>3.0.co;2-m.
3
Benefit Cost Analysis of Three Skin Cancer Public Education Mass-Media Campaigns Implemented in New South Wales, Australia.澳大利亚新南威尔士州实施的三项皮肤癌公共教育大众媒体宣传活动的效益成本分析。
PLoS One. 2016 Jan 29;11(1):e0147665. doi: 10.1371/journal.pone.0147665. eCollection 2016.
4
Screening for malignant melanoma: A cost-effectiveness analysis.恶性黑色素瘤筛查:一项成本效益分析。
J Am Acad Dermatol. 1999 Nov;41(5 Pt 1):738-45. doi: 10.1016/s0190-9622(99)70010-1.
5
Economic evaluation of ACE inhibitor treatment of nephropathy in patients with insulin-dependent diabetes mellitus in Italy.意大利胰岛素依赖型糖尿病患者肾病的血管紧张素转换酶抑制剂治疗的经济学评估
Pharmacoeconomics. 1997 Jul;12(1):67-75. doi: 10.2165/00019053-199712010-00007.
6
Cost-Effectiveness Analysis of a Skin Awareness Intervention for Early Detection of Skin Cancer Targeting Men Older Than 50 Years.针对50岁以上男性的皮肤癌早期检测皮肤意识干预措施的成本效益分析。
Value Health. 2017 Apr;20(4):593-601. doi: 10.1016/j.jval.2016.12.017. Epub 2017 Feb 15.
7
Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review.皮肤癌的卫生系统成本以及皮肤癌预防与筛查的成本效益:一项系统评价
Eur J Cancer Prev. 2015 Mar;24(2):141-9. doi: 10.1097/CEJ.0000000000000056.
8
[A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].[在意大利国家和地区层面使用RIX4414疫苗对轮状病毒进行广泛疫苗接种的全面经济评估]
Ann Ig. 2013 Jan-Feb;25(1):43-56. doi: 10.7416/ai.2013.1905.
9
Cost effectiveness and cost utility of adjuvant interferon alpha in cutaneous melanoma: a review.皮肤黑色素瘤辅助性干扰素α的成本效益和成本效用:一项综述
Pharmacoeconomics. 2004;22(9):569-80. doi: 10.2165/00019053-200422090-00002.
10
Estimated Healthcare Costs of Melanoma in Australia Over 3 Years Post-Diagnosis.澳大利亚黑色素瘤患者确诊后 3 年的预估医疗费用。
Appl Health Econ Health Policy. 2017 Dec;15(6):805-816. doi: 10.1007/s40258-017-0341-y.

引用本文的文献

1
Modelling the healthcare costs of skin cancer in South Africa.南非皮肤癌的医疗成本建模。
BMC Health Serv Res. 2016 Apr 2;16:113. doi: 10.1186/s12913-016-1364-z.

本文引用的文献

1
A proposal for Italian guidelines in pharmacoeconomics The Mario Negri Institute Centre for Health Economics.意大利药物经济学指南提案 马里奥·内格里研究所卫生经济中心
Pharmacoeconomics. 1995 Jan;7(1):1-6. doi: 10.2165/00019053-199507010-00001.
2
Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis.医疗保健技术经济评估中的不确定性:敏感性分析的作用。
Health Econ. 1994 Mar-Apr;3(2):95-104. doi: 10.1002/hec.4730030206.
3
Current therapy for cutaneous melanoma.
J Am Acad Dermatol. 1995 May;32(5 Pt 1):689-707; quiz 708-9. doi: 10.1016/0190-9622(95)91443-9.
4
Prognosis of stage I melanoma of the skin. Who collaborating centres for evaluation of methods of diagnosis and treatment of melanoma.皮肤I期黑色素瘤的预后。世界卫生组织黑色素瘤诊断和治疗方法评估合作中心。
Int J Cancer. 1980 Dec 15;26(6):733-9. doi: 10.1002/ijc.2910260606.
5
Malignant melanomas of the skin diagnosed and treated in Albuquerque, New Mexico, in 1980.
J Dermatol Surg Oncol. 1982 Jan;8(1):40-3. doi: 10.1111/j.1524-4725.1982.tb00233.x.
6
Risk for cutaneous melanoma in recent Connecticut birth cohorts.康涅狄格州近期出生队列中患皮肤黑色素瘤的风险。
Am J Public Health. 1985 Jun;75(6):679-82. doi: 10.2105/ajph.75.6.679.
7
[Cutaneous melanoma at the Turin Melanoma Center. I. Survival and correlation with clinical and histologic prognostic factors in 502 patients in stage I (1975-1985)].[都灵黑色素瘤中心的皮肤黑色素瘤。I. 502例I期患者(1975 - 1985年)的生存率及其与临床和组织学预后因素的相关性]
G Ital Dermatol Venereol. 1986 Sep-Oct;121(5):311-26.
8
Melanoma case survival rates in South Australia by histological type, thickness and level of tumour at diagnosis.南澳大利亚州黑色素瘤病例按组织学类型、厚度及诊断时肿瘤分期划分的生存率。
Med J Aust. 1986 Jun 23;144(13):680-2. doi: 10.5694/j.1326-5377.1986.tb113693.x.
9
The rate of malignant melanoma in the United States: are we making an impact?
J Am Acad Dermatol. 1987 Dec;17(6):1050-3. doi: 10.1016/s0190-9622(87)80487-5.
10
Skin cancer in Australia.
Med J Aust. 1989 May 1;150(9):469-70. doi: 10.5694/j.1326-5377.1989.tb136585.x.